Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia: The ORION-2 Pilot Study.
Circulation
; 141(22): 1829-1831, 2020 06 02.
Article
in En
| MEDLINE
| ID: mdl-32479195
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Therapy
/
RNA, Small Interfering
/
RNA Interference
/
Molecular Targeted Therapy
/
PCSK9 Inhibitors
/
Hyperlipoproteinemia Type II
/
Cholesterol, LDL
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Circulation
Year:
2020
Document type:
Article
Country of publication:
United States